Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Lol I was speaking of an investor conference, not earnings call.
No, he is simply not one of the legit analysts that cover the stock. If there was an investor conference, there is a list of sell side analysts that cover the stock that would be invited. That is a public list.
Not everyone is a covering analyst if they put out an “analysis” on a company. Only 1 covering analyst has a sell rating vs 10 that recommend Buy.
Basics of investing here.
ARK bought $30M of TSLA over the past week. Lol
Except he is just a fake analyst. Out of the legit analysts that actually cover the stock the lowest target price is $325 and highest is $1,580.
I use TD and don’t see any pre-market action. Usually any pre-market is for prior day settlement.
Goldman Sachs maintains Buy rating on TSLA.
Buy: 10 Analysts
Hold: 4 Analysts
Sell: 1 Analyst
Consensus price: $890.67
Duration of shortage: 09/12/2019 - 05/31/2022
Been an issue for a while
Not a bad recap. Can’t talk about pipeline since very little has been divulged.
Nice volume 1H of session and then died after lunch.
That won’t even be filed until next calendar year. Non-news event until the study is done and successful.
But did you close your short position before it went green again? If so, congrats to you. Until then, I’ll enjoy the positive momentum until I close out my long position.
That’s pre-market. Never trust OTC Bid/Ask pre-market. Even during session it questionable. Not held to same regulations as an exchange.
Fake news. Lol, Im sure you shorted at $1,200. Yeah right.
Psst. As of 10:22 CST, S&P futures are still up.
Hard to sell when there are no buyers.
No, that would be justifiable forward multiple. Why is the stock price lower than analyst consensus? If it wasn’t that would be a bubble. Close your short position before it’s too late.
Lol How old of a company is Toyota compared to Tesla? No company has grown to the size of Tesla as fast as they have. Ever.
Happy short position getting smoked! Lol
Lol, not a chance. Tesla has a monstrous backlog. Demand is off the charts compared to any other in the industry. 2022 is sold out. People cant get their orders filled until 2023. That’s not a sign of weakness. Tesla will be practically immune to any potential recession due to the massive backlog.
Stock is only going to keep rolling higher. Crédit Suisse just reiterated share price target of $1,125. Better close that short position before it’s too late.
Looks like you have got burned over the last 2 weeks with the aggressive reversal from the floor. Lol
Funny how there is no date or link as this is news from several months ago regarding a forward split to take place later this year. Oftentimes the stock price will rise even more aggressively after a stock split. This isn’t bad news, this is great news…unless you have a short position.
Not sure why anyone would ever look at book value for disruptive, high growth, highly profitable companies. That’s just ridiculous. There is a reason why Tesla has such a high forward multiple due to the market being forward looking. Tesla will go beyond just the retail consumer automotive industry.
Except for the fact it is up 2.3% on Frankfurt exchange. Nice try.
And when that happens the competition is even more fierce and will have to start over in penetrating the market from scratch. Not a great position to be in.
Either way, both products are minimal to what Adderall ER can do if Lannett can penetrate market to what IR has done. Hopefully soon, we can completely ignore Loxapine, trimipramine and isradipine,
etc as peanuts.
Per last cc, “Isradipine and Trimipramine are being marketed by our partner Epic. They are interesting products because they are a very -- they have very limited competition. With Epic, we are seeing a little more profit and revenues for this product than we have before.”
Good thing he hasn’t been right once and that the CEO has stated it many times in conference calls.
You should really start looking into facts. Lithium ion batteries can burst into flame, but not explode. How many fuel-based cars burst into flames each year? About 200K.
For every 50,000 fuel-based vehicles that burst into flames you have about one Tesla that does as well.
Exactly. For SequestOx they did a late Friday evening 8K if I remember right as that was before they had much revenue coming in so perhaps was more justified and after CEO said FDA couldn’t stop them. Well they most certainly did. Elite still doesn’t have much revenue coming in, but it’s more than that time period. I recall another CRL being buried in a 10K or Q as well that wasn’t previously communicated.
Looks like someone is holding a naked short position and starting to sweat.
Not necessarily. Company has been inconsistent with communication of any CRLs received.
Maybe, just maybe, Elite could find an analyst to cover it within the next couple years bringing more attention to the stock.
And if it rises with NASDAQ pursuits and ownership from investment funds the opposite takes place.
Shareholder value doesn’t change with a R/S.
They’ll R/S
They are going to qualify next year for the more exclusive NASDAQ Global Select option, which is exactly what I laid out.
More eyes on the prize.
NASDAQ in 2023?
There are a few ways Elite can uplist to the NASDAQ and only one option is even remotely realistic.
1. Market Cap of $550M with cash flow of $27.5M in aggregate. (Not even close w/ market cap)
2. Assets of $80M & Shareholder equity of $55M. (Not a chance here either)
3. Market cap of $850M and revenues exceeding $90M. (Goose egg on market cap & rev threshold)
4. $11M in pre-earnings over prior 3 years without a net loss. (Getting close)
Earnings are Elite’s only viable path to NASDAQ near term. We had a net loss in FY20, but made the cut last year and I expect that Elite will profitable again this year. This means that we are on track to meet NASDAQ’s min requirements with the filing of our 10K next year (one year from next month).
If stars align, we expect more filings this year and next, which will start driving some attention and stock price up with a potential uplisting to NASDAQ riding on the filing momentum, stability and future growth.
One year and counting (+/- few months) to get off the OTC. And that is good news.
Most volume we’ve had in a session for a while…unless you prefer those 15k volume days.
That’s also not how vesting works. Not sure why you are posting this on an LCI board. Off topic.
That is not how options work. That is not even remotely correct.
Very little sitting on the bid, which means price can’t be supported.
This is all public info.
2019 Rev = 24.5M
2021 Rev = 53.8M
Revenue is just part of the story why the stock rose so quickly over the past 2 years. Tesla was expected to own the EV market as major manufacturers delayed R&D, but we have a different competitive landscape now as well, which gives us a different forward look on which the stock price would be based and a weaker stock multiple.